Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 3, 2002 - Issue 8
Submit an article Journal homepage
186
Views
181
CrossRef citations to date
0
Altmetric
Miscellaneous

Opinion on the diagnosis and treatment of human trichinellosis

Fabrizio Bruschi Department of Experimental Pathology, BMIE, University of Pisa, via Roma 55, 56126 Pisa, Italy
,
Jean Dupouy-Camet Parasitology Department, Hôpital Cochin, Université R. Descartes, 27 rue du Faubourg St Jacques, 75014 Paris, France, Tel. +33 158 412 251; Fax +33 158 412 245; , E-mail: [email protected]
,
Wanda Kociecka Department of Parasitic and Tropical Diseases, Karol Marcinkowski University of Medical Sciences, Przybyszewskiego st. 49, 60-355 Poznan, Poland
,
Edoardo Pozio Laboratory of Parasitology, Istituto Superiore di Sanità, viale Regina Elena 299, 00161 Rome, Italy
&
Francisco Bolas-Fernandez Department of Parasitology, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramon y Cajal s/n, 28040 Madrid, Spain
Pages 1117-1130 | Published online: 25 Feb 2005

Bibliography

  • POZIO E: New patterns of Trichinella infections. Vet. Parasitol (2001) 98:133–148.
  • POZIO E: Factors affecting the flow amongdomestic, synanthropic and sylvatic cycles of Trichinella. Vet. Parasitol (2000) 93:241–262.
  • MURRELL KD, LICHTENFELS RJ, ZARLENGA DS, POZIO E: The system-atics of the genus Trichinella with a key to species. Vet. Parasitol (2000) 93:293–307.
  • KAPEL CM: Host diversity and biological characteristics of the Trichinella genotypes and their effect on transmisssion. Vet. Parasitol (2000) 93:263–278.
  • DUPOUY-CAMET J: Trichinellosis: a worldwide zoonosis. Vet. Parasitol (2000) 93:191–200.
  • MURRELL KD, POZIO E: Trichinellosis: the zoonosis that won't go quietly. Int. .1. Parasitol (2000) 30:1339–1349.
  • DESPOMMIER DD: Biology. In: Trichinella andTrichinosis. Campbell WC (Ed.), Plenum Press, New York, USA (1983):75–151.
  • BASSET D, THIEBAUT MM, PRATLONG F et al.: Two familial outbreaks of trichinellosis in the Languedoc region of France due to ingestion of wild boar meat. Sem. Hop. Paris (1996) 72:567–568.
  • MURRELL KD & BRUSCHI F: Clinicaltrichinellosis. In: Progress in Clinical Parasitology Tsieh Sun (Ed.), CRC Press, Boca Raton, USA (1994):117–150.
  • •A good comprehensive review of clinical trichinellosis.
  • CAPO V, DESPOMMIER D: Clinical aspects of infection with Trichinella spp. Clin. Microbic] Rev (1996) 9:47–54.
  • KOCIECKA W: Trichinellosis: human disease, diagnosis and treatment. Vet. Parasitol (2000) 93:365–383.
  • FROSCHER W, GULLOTTA F, SAATHOFF M, TACKMANN W: Chronic trichinosis. Clinical, bioptic, serological and electromyographic obs-ervations. Eur. Neurol (1988) 28:221–226.
  • FOURESTIE. V, DOUCERON H, BRUGIERES P, ANCELLE T, LEJONC JL, GHERARDI RK: Neurotrichinosis. A cerebrovascular disease associated with myocardial injury and hypereosinophilia. Brain (1993) 116:603–616.
  • •Interesting article reporting cases and reviewing factors involved in brain and heart complications of trichinellosis.
  • XU B, CHANG J, GAO G et al: Four outbreaks of human trichinellosis in Henan province. Chinese Med. J. (1995) 108:872–874.
  • DUPOUY-CAMET J, ANCELLE T, LAVARDE V, LAPIERRE J: Aspects cliniques de l'épidémie de trichinose d'aotat 1985 à Melun et Paris. Buff. Societe Franraise Parasitol (1985) 2:21–24.
  • ANCELLE T, DUPOUY-CAMET J, BOUGNOUX ME et al.: Two outbreaks of trichinosis caused by horsemeat in France in 1985. Am..! Epidemiol (1988) 127:1302–1311.
  • •Comparison of two outbreaks related to different Trichinella species.
  • ANCELLE T, DUPOUY-CAMET J, DESENCLOS JC et al.: A multifocal outbreak of trichinellosis linked to horse meat imported from North America to France in 1993. Am. Trop. Med. Hyg. (1998) 59:615–619.
  • BESSOUDO R, MARRIE TJ, SMITH ER Cardiac involvement in trichinosis. Chest (1981) 79:698–699.
  • COMPTON SJ, CELUM CL, LEE C et al.: Trichinosis with ventilatory failure and persistent myocarditis. Clin. Infect. Dis. (1993) 16:500–504.
  • ELLRODT A, HALFON P, LE BRAS P et al.: Multifocal central nervous system lesions in three patients with trichinosis. Arch. Neurol (1987) 44:432–434.
  • RYCZAK M, SORBER WA, KANDORA TF, CAMP CJ, ROSE FB: Difficulties in diagnosing Trichinella encephalitis. Am. Bop. Med. Hyg. (1987) 36:573–575.
  • TARATUTO AL, VENTURIELLO SM: Trichinosis. Brant Pathol (1997) 7:663–672.
  • FEYDY A, TOUZE E, MIAUX Y et ak MRI in a case of neurotrichinosis. Neuroradiology (1996) 38:S80–S82.
  • PAWLOWSKI ZS: Clinical aspects in man. In: Trichinella and trichinosis. Campbell WC (Ed.), Plenum Press, New York, USA and London, UK (1983):367–401.
  • DUPOUY-CAMET J, ANCELLE T, FOURESTIE. V, BOIREAU P, SOULE. C: Trichinelloses. In: Maladies infectieuses Encycl. Med. Chir. (Ed.) Elsevier, Paris, France (1998):8-517-A–10.
  • VIALLET J, MACLEAN JD, GORESKY LA, STAUDT M, GAETANE R, LAW C: Arctic trichinosis presenting as prolonged diarrhea. Gastroenterology (1986) 91:938–946.
  • MACLEAN JP, VIALLET J, LAW C, STUART M: Trichinosis in the Canadian Arctic: report of five outbreaks and a new clinical syndrome. 1 Infect. Dis. (1989) 160:513–520.
  • PIELOK L: Clinical analysis and evaluationof selected laboratory parameters in patients examined in distant periods after trichinellosis. Wiad. Parazytol (2001) 47:185–209.
  • •A discussion on chronic trichinellosis.
  • HARMS G, BINZ P, FELDMEIER H et al.: Trichinosis: a prospective controlled study of patients ten years after acute infection. Clin. Infect. Dis. (1993) 17:637–643.
  • •A good discussion of chronic trichinellosis.
  • KOCIECKA W: Trichinosis. In: Parasitic Infections in Pregnancy and the Newborn. MacLoad C (Ed.), Oxford Medical Publications, Oxford University Press, UK (1988):216–226.
  • DOBY JM, COUATARMANAC'H A, CAMPION JP, BEURTON D, GENDRE B: Trichinose humaine et immuno-depression. Un cas chez un greffé renal.
  • •• Med. Ma/ad. Infect. (1984) 14:293–298.
  • LOUTHREN00 W, MAHANUPHAB P, SANGUANMITRA P, THAMPRASERT K: Trichinosis mimicking polymyositis in a patient with human immunodeficiency virus infection. Br. J. Rheumatol (1993) 32:1025–1026.
  • JACOBSON ES, JACOBSON HG: Trichinosis in an immunosuppressed human host. Am. j Clin. Pathol (1977) 68:791–794.
  • BRUSCHI F & MURRELL KD: New aspects of human trichinellosis: the impact of new Trichinella species. Postgrad. Med. (2002) 78:15–22.
  • ••The recent aspects of clinical trichinellosis.
  • POZIO E, VARESE P, GOMEZ-MORALES MA, CROPPO GP, PELLICCIA D, BRUSCHI F: Comparison of human trichinellosis caused by Trichinella spiralis and by Trichinella britovi Am. J. Trop. Med. Hyg. (1993) 48:568–575.
  • DUPOUY-CAMET J, PAUGAM A, DE PINIEUX G, LAVARDE V, VIEILLEFOND A: Trichinella marl-dB pathological features in human muscles at different delays after infection. Parasite (2001) 8:S176–S179.
  • JONGWUTIWES S, CHANTACHUM N, KRAIVICHIAN P et al.: First outbreak of human trichinellosis caused by Trichinella pseudospiralis. Clin. Infect. Dis. (1998) 26:111–115.
  • RANQUE S, FAUGERE B, POZIO E et al.: Trichinella pseudospiralis outbreak in France. Emerg. Infect. Dis. (2000) 6:543–547.
  • FERRACCIOLI GF, MERCADANTI M, SALAFFI F, BRUSCHI F, MELISSARI M, POZIO E: Prospective rheumatological study of muscle and joint symptoms during Trichinella nelsoni infection. Q. I Med. (1988) 69:973–984.
  • VAN KNAPEN F, FRANCHIMONT JH, VERDONK AR, STUMPF J, UNDEUTSCH K: Detection of specific immunoglobulins (IgG IgM, IgA, IgE) and total IgE levels in human trichinosis by means of the enzyme-linked immunosorbent assay (ELISA). Am. I Bop. Med. Hyg. (1982) 31:973–976.
  • LJUNGSTROM I: Immunodiagnosis in man. In: Trichinella and Trichinosis, Campbell WC (Ed.), Plenum Press, New York, USA (1983):403–424.
  • BRUSCHI F, TASSI C, POZIO E: Parasite-specific antibody response in Trichinella sp. 3 human infection: a one year follow-up. Am. J. Trop. Med. Hyg. (1990) 43:186–193.
  • BRUSCHI F, MORETTI A, WASSOM D, PIERGILI FIORETTI D: The use of a synthetic antigen for the serological diagnosis of human trichinellosis. Parasite (2001) 8:S141–S143.
  • COSTANTINO SN, MALMASSARI SL, DALLA FONTANA ML, DIAMANTE MA, VENTURIELLO SM: Diagnosis of human trichinellosis: pitfalls in the use of a unique immunoserological technique. Parasite (2001) 8:S144–S146.
  • ANDIVA S, YERA H, HAEGHEBAERT S, TOURTE-SCHAEFER C, MAGNAVAL JF, DUPOUY-CAMET J: Comparative evaluation of a latex agglutination test, two Elisa kits and a western blot kit for the serodiagnosis of human trichinellosis. Ann. Biol. Clin. (Paris) (2002) 60:79–83.
  • MORAKOTE N, KHAMBOONRUANG C, SIRIPRASERT V, SUPHAWITAYANUKUL S, MARCANANTACHOTI S, THAMASONTHI W: The value of enzyme-linked immunosorbent assay (ELISA) for diagnosis of human trichinosis. Trop. Med. Parasitol (1991) 42:172–174.
  • ZARLENGA DS, LA ROSA G: Molecular and biochemical methods for parasite differentiation within the genus Trichinella. Vet. Parasitol (2000) 93:279–292.
  • WRANICZ MJ, GUSTOWSKA L, GABRYEL P, KUCHARSKA E, CABAJ W: Trichinella spiralis: induction of the basophilic transformation of muscle cells by synchronous newborn larvae. Parasitol Res. (1998) 84:403–407.
  • GAMBLE HR, BESSONOV AS, CUPERLOVIC K et al.: International Commission on Trichinellosis: recommendations on methods for the control of Trichinella in domestic and wild animals intended for human consumption. Vet. Parasitol (2000) 93:393–408.
  • •Describe the sample digestion method for Trichinella testing.
  • KOCIECKA W, BOMBICKI K, PIELOK E, GUSTOWSKA L: New aspects of clinical pathology and electrophysiological muscle disturbances in patients with history of trichinellosis. Parasite (2001) 8:S173–S175.
  • THIENPONT D, VANPARIJS OF, VANDENSTEENE R: Anthelmintic and histopathological effects of mebendazole on Trichinella spiralisin the rat. In: Trichinellosis. Proceedings of the 3rd International Conference on Trichinellosis. Kim CW (Ed.), Educational Publishers, New York, USA (1972):515–527.
  • MAC CRACKEN RO: Efficay of mebendazole and albendazole against Trichinella spiralis in mice. J. Parasitol (1978) 64:214–219.
  • BOLAS-FERNANDEZ F, SANMARTIN-DURAN ML, MARTINEZ-FERNANDEZ AR: The influence of immunomodulating drugs (niridazole and cyclophosphamide) on the effect of mebendazole on encysted larvae of Trichinella spiralis. In: Trichinellosis. Proceed-ings of the 5th International Conference on Trichinellosis. Kim CW, Ruitenberg EJ, Teppema JS (Eds), Reedbooks Ltd., Surrey, UK (1981):337–342.
  • CAMPBELL WC, DENHAM DA: Chemotherapy. In: Trichinella and trichinosis. Campbell WC (Ed.), Plenum Press, New York, USA (1983):335–366.
  • •An exhaustive review of compounds tested to treat experimental trichinellosis.
  • MARINCULIC A, FAJDIGA M & DURAKOVIC E: The efficacy of flubendazole against Trichinella spiralis in swine. Parasite (2001) 8:191–194.
  • KIM CW, CAMPBELL WC, LIEBMAN ML: Trial of ivermectin against the muscle phase of trichinellosis in mice. In: Trichinellosis. Proceedings of the 7th International Conference on Trichinellosis. Tanner CE, Martinez-Fernandez AR, Bolas-Fernandez F (Eds), CSIC Press, Madrid, Spain (1988):478–483.
  • TAYLOR SM, PEARSON GR: The effect of a single injection of ivermectin on encysted muscle larvae of Trichinella spiralis in experimentally infected pigs. In: Trichinellosis. Proceedings of the 5th International Conference on Trichinellosis. Kim CW, Ruitenberg EJ, Teppema JS (Eds), Reedbooks, Chertsey, UK (1980)353–357.
  • FOURESTIE V, BOUGNOUX ME, ANCELLE T et al.: Randomized trial of albendazole versus thiabendazole plus flubendazole during an outbreak of human trichinellosis. Parasitol Res. (1988) 75:36–41.
  • •The first randomized trial comparing different anthelmintics.
  • CABIE A, BOUCHAUD 0, HOUZE S et al.: Albendazole versus thiabendazole as therapy for trichinosis: a retrospective study. Clin. Infect. Dis. (1996) 22:1033–1035.
  • WATT G, SAISORN S, JONGSAKUL K, SAKOLVAREE Y, CHAICUMPA W: Blinded placebo-controlled trial of antiparasitic drugs for trichinosis myositis. Infect. Dis. (2000) 182:371–374.
  • ••An interesting placebo-controlled trial ofanthelmintics but including only a small number of patients in the different arms.
  • WALSH DS, JONGSAKUL K, WATT G: Hand rash in trichinosis. Clin. Exp. Dermatol (2001) 26:272–273.
  • BRAITHWAITE PA, ROBERTS MS, ALLAN RJ, WATSON TR: Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. Eur. Clin. Pharmacol (1982) 22:161–169.
  • BEKHTI A, PIROTTE J: Cimetidine increases serum mebendazole concentrations. Implications for treatment of hepatic hydatid cysts. Br. I Clin. Pharmacol (1987) 24:390–392.
  • MARTINDALE: Anthelmintics/ mebendazole. In: The Extra Pharmacopeia. Reynolds JEF (Ed.), Royal Pharmaceutical Society, London, UK (1996):109–110.
  • DE SILVA NR, SIRISENA JLG, GUNASEKERA DPS, ISMAIL MM, DE SILVA HJ: Effect of mebendazole therapy during pregnancy on birth outcome. Lancet (1999) 353:1145–1149.
  • GENDREL D, ARNAUD-BATTANDIER F, RICHARD-LENOBLE D: Intestinal parasitosis in the immunocompetent child (in French). In: Castroentérologie Pédiatrique. Navarro J & Schmitz J (Eds), Flammarion, Paris, France (2000):420–429.
  • KLEIN J, ZAKHARENKO DF, DOLGINA LE, BRAGINETZ WR, LINKOIA CW: Etiotropic therapy and prophylaxis of trichinellosis. In: Trichinellosis. Proceedings of the 5th International Conference on Trichinellosis. Kim CW, Ruitenberg EJ, Teppema JS (Eds), Reedbooks, Chertsey, UK (1980):291–296.
  • KOCIECKA W, GUSTOWSKA L, MROZEWICZ B: Effect of early prophylactic therapy in patients infected with T spiralis. In: Trichinellosis. Proceedings of the 9th International Conference on Trichinellosis. Ortega-Pierres G, Gamble R, Van Knapen F, Wakelin D (Eds), Germar Press, Nonoalco Tlateloco, Mexico (1996):635–641.
  • OZEREZTKOVSKAYA NN, MORENETZ TM, PEREVERZEVA EV et al.: Therapeutical properties of benzimidazoles in trichinellosis and the side effects of the treatment. In: Trichinellosis. Proceedings of the 5th International Conference on Trichinellosis. Kim CW, Ruitenberg EJ, Teppema JS (Eds), Reed-books, Chertsey, England (1980):287–290.
  • POZIO E, SACCHINI D, SAC CHI L, TAMBURRINI A, ALBERICI F: Failure of mebendazole in treating Trichinella spiralis infection in humans at the stage of encapsulating larvae. Clin. Infect. Dis. (2001) 32:638–642.
  • LEVIN ML: Treatment of trichinellosis with mebendazole. Am. I Bop. Med. Hyg. (1983) 32:980–983.
  • MARRINER SE, MORRIS DL, DICKSON B, BOGAN JA: Pharmacokinetics of albendazole in man. Eur. Clin. Pharmacol (1986) 30:705–708.
  • LANGE H, EGGERS R, BIRCHER J: Increased systemic availability of albendazole when taken with a fatty meal. Eur. Clin. Pharmacol (1988) 34:315–317.
  • JUNG H, HURTADO M, SANCHEZ M, MEDINA MT, SOTELO J: Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. Clin. Pharmacol (1992) 32:28–31.
  • KOCIECKA W, STEFANIAK J, KACPRAZAK E, PAKULA M: Clinical evaluation of albendazole in the therapy of human trichinellosis. Wiadomosci Parazytologiczne (1989) 34:457–466.
  • HORTON RJ: Chemotherapy of Echinococcus infection in man with albendazole. Transact. Royal Soc. Bop. Med. Hyg. (1989) 83:97–102.
  • MARTINDALE: Anthelmintics/ albendazole. In: The Extra Pharmacopeia. Reynolds JEF (Ed.), Royal Pharmaceutical Society, London, UK (1996):118–119.
  • HORTON J: The use of antiprotozoan and anthelmintic drugs during pregnancy and contraindications. J. Infect. (1993) 26:104–105.
  • AUER H, KOLLARITSCH H, JOPTNER J, ASPOCK H: Albendazole and pregnancy. Appl. ParasitoL (1994) 35:146-147. ao.BRADLEY M & HORTON J: Assessing the risk of benzimidazole during pregnancy. Transact. Royal Soc. Bop. Med. Hyg. (2001) 95:72–73.
  • LOPEZ ML, TORRADO S, SANTIAGO T, MARTINEZ AR, BOLAS F: Improvement of albendazole efficacy against enteral but not against parenteral stages of Trichinella spiralis by preparing solid dispersions on polyvinylpyrrolidone. Chemotherapy (1997) 43:430-435. Improvement of albendazole efficacy by new formulations but on experimental models.
  • TORRADO S, LOPEZ ML, TORRADO G, BOLAS F, SANTIAGO T, CADORNIGA R: A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation. hat. Pharm. (1997)156:181–187.
  • CASTILLO JA, PAALOMO-CANALES J,GARCIA JJ, LASTRES JL, BOLAS F, TORRADO JJ: Preparation and characterization of albendazole-cyclodextrin complexes. Drug Dev. Ind. Pharm. (1999) 25:1241–1248.
  • LOPEZ-GARCIA ML, TORRADO-SUSANA S, TORRADO-SANTIAGO S, MARTINEZ AR, BOLAS F: Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose regime. Vet. Parasitol (1998) 75:209–219.
  • •Improvement of albendazole efficacy by new formulations but on experimental models.
  • JUNG H, HURTADO M, MEDINA MT, SANCHEZ M, SOTELO J: Dexamethasone increases plasma levels of albendazole. Neurol (1990) 237:279–280.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.